Spectral Diagnostics Inc. (OTCMKTS:EDTXF – Get Free Report) saw a significant drop in short interest in April. As of April 30th, there was short interest totaling 6,989 shares, a drop of 60.8% from the April 15th total of 17,844 shares. Based on an average trading volume of 9,266 shares, the days-to-cover ratio is currently 0.8 days. Currently, 0.0% of the company’s stock are sold short.
Spectral Diagnostics Trading Down 2.0%
OTCMKTS:EDTXF traded down $0.02 during trading hours on Thursday, hitting $1.02. The stock had a trading volume of 5,140 shares, compared to its average volume of 9,791. Spectral Diagnostics has a 1-year low of $0.58 and a 1-year high of $1.31. The business has a 50 day simple moving average of $1.00 and a two-hundred day simple moving average of $0.99. The company has a market cap of $298.99 million, a PE ratio of -10.19 and a beta of 0.09.
Spectral Diagnostics (OTCMKTS:EDTXF – Get Free Report) last issued its quarterly earnings data on Friday, May 8th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). The firm had revenue of $0.64 million during the quarter, compared to analyst estimates of $0.54 million.
About Spectral Diagnostics
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.
Featured Stories
- Five stocks we like better than Spectral Diagnostics
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
- The Great SPR Arbitrage: An Oil Market Glitch Fuels Sector Gains
- Why Satellogic Could Be One of the Biggest Space Winners of 2026
Receive News & Ratings for Spectral Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
